Hyaluronic Acid-Modified Nanoparticles Loaded with Cabazitaxel: A Promising Nanomedicine for Malignant Prostate Tumors
HA-CTX NPs represent a promising nanomedicine for prostate tumor treatment, offering improved efficacy and reduced side effects compared to conventional CTX formulations.
Authors
- L. J. Chen
- Yating Ji (ORCID: https://orcid.org/0009-0005-6942-7867)
- Meng Zhang (ORCID: https://orcid.org/0000-0001-5630-321X)
- Zehao Li (ORCID: https://orcid.org/0009-0000-8801-4279)
- Na Qu (ORCID: https://orcid.org/0000-0001-7446-8552)
- Zhihang Li
Institutions
- Liaoning University (CN)
Publication Details
- Journal
- Current Drug Delivery
- Published
- 2026-01-08
- DOI
- https://doi.org/10.2174/0115672018415982251117074725
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00